News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proteus Biomedical, Inc. Raises $17.5 Million



5/17/2012 8:50:53 AM

Here are fundings from Silicon Valley companies, announced or filed recently with the U.S. Securities and Exchange Commission.

The Funded is a recurring feature where we post new fundings that cross our desks, as well as an archive of past fundings.

Proteus Biomedical Inc. raises $17.5M of $50M round

The Redwood City-based health care company sold equity to raise the funds. The parties listed on the filing include: Joy Berberich, executive; Benjamin Costello, executive; Lorenzo Di Carlo, executive; Frank Fischer, director; Terry Gould, director; Erika Karplus, executive; Alan Levy, director; David O'Reilly, executive; Ben Pless, director; Timothy Robertson, executive; George Savage, executive; Ryan Schwarz, director; Immanuel Thangaraj, director; Andrew Thompson, executive, director; Todd Thompson, executive; Mark Zdeblick, executive, director.

Proteus is a private company. Its investors include: Adams Street Partners, Asset Management, The Carlyle Group, Essex Woodlands, Fletcher Spaght Ventures LP, Kaiser Permanente Ventures and Spring Ridge Ventures. The company makes digestible sensors made from food ingredients, which can record information such as a drug type or dosage.




comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES